LRRK2 – Parkinson’s, Leprosy, and Crohn’s

LRRK2 – Parkinson’s, Leprosy, and Crohn’s
Researchers at the University of Ottawa have announced a new discovery associated with a genetic form of Parkinson's. Individuals with a genetic variation in a region of DNA for leucine-rich repeat kinase-2 (or simply LRRK2) have a higher risk of developing Parkinson's, as well as leprosy, and Crohn’s disease. Why this is the case has been a mystery for a ... read more
Source: The Cure Parkinson’s TrustPublished on 2019-10-03